Wantai Bio: It is expected that the net profit in the first half of 2022 is 2.5 billion yuan to 2.75 billion yuan, an increase of 246%to 281%year -on -year

Every time AI News, Wantai Biological (SH 603392, closing price: 159 yuan) issued a performance preview on the evening of July 11. It is expected that the net profit attributable to the owner of the parent company in 2022 is 2.5 billion yuan to 2.75 billion yuan. Compared with the same period last year, it will increase by about 1.778 billion yuan to about 2.028 billion yuan, an increase of 246%to 281%year -on -year.

From January to December 2021, the operating income of Wantai Biological is 58.48%of the vaccine and 40.68%of in vitro diagnosis.

As of press time, Wantai's biological market value is 140 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. Wantai Bio has a decrease of 375,600 shares in northern direction in the past 30 days, accounting for 0.17%of the proportion of circulating shares;

2. There is no opportunity to investigate Wantai Bio in the past 30 days;

3. According to the predictions of the net profit of Wantai Bio, the average net profit average of Wantai Bio's semi -annual prediction in 2022 was 2.046 billion yuan. Wantai Bio had a net profit of 722 million yuan in the same period last year.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Every headline (NBDTOUTIAO) - "Cosmic Center Disclosure" -Caoxian: Red, still want to be red

(Reporter Yin Hualu)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -